Bioelectronics Corp (BIEL)

[kidnova]

No, I'm not talking about planning for failure, I'm talking about running a company responsibly. Most development stage companies, which BIEL claims to be, attempt to minimize expenses. Bio-techs, in particular, can go years with zero marketing and sales expense while they focus on R&D and regulatory clearance.

If BIEL had a profitable line of products that were helping to support their development then that would be a different story, but they don't. The shotgun approach they are taking to marketing their product has been a dismal failure to date and I don't see that changing unless they receive FDA approval. The money they are currently spending on marketing and salaries would be better deployed conducting further studies to more adequately prove that the product is both safe and effective.

It's all my opinion, obviously, but I believe they would have a better chance at long term success if they went this route.